Liver Resection for Hepatocellular Carcinoma on Cirrhosis: Univariate and Multivariate Analysis of Risk Factors for Intrahepatic Recurrence

Annals of Surgery

Volumn 237, Issue 4, 2003, Pages 536-543

  Ercolani, Giorgio ^a   Grazi, Gian Luca ^a   Ravaioli, Matteo ^a   Del Gaudio, Massimo ^a   Gardini, Andrea ^a   Cescon, Matteo ^a   Varotti, Giovanni ^a   Cetta, Francesco ^b   Cavallari, Antonino ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN THROMBOSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; DISEASE FREE SURVIVAL; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0038460305     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200304000-00016     Document Type: Article

References (32)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-285.
2. Parkin DM, Stjersward J, Muir CS. Estimates of worldwide frequency of twelve major cancers. Bull World Health Organ. 1984;62:729-738.
3. Makuuchi M, Takayama T, Kubota K, et al. Hepatic resection for hepatocellular carcinoma - Japanese experience. Hepato-Gastroenterology. 1998;45(Suppl 3):1267-1274.
4. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resections for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234:71-78.
5. Yamanaka N, Okamoto E, Toyosaka A, et al. Prognostic factors after hepatectomy for hepatocellular carcinoma. A univariate and multivariate analysis. Cancer. 1990;65:1104-1110.
6. Shirabe K, Kanematsu T, Matsumata T, et al. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analysis. Hepatology. 1991;14:802-805.
7. Belghiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114-117.
8. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105:488-494.
9. Noun R, JaAST P, Farges O, et al. High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A cirrhotic patients. World J Surg. 1997;21:390-395.
10. Farges O, Malassagne B, Flejou J, et al. Risk of major liver resection in patients with underlying chronic liver disease. Ann Surg. 1999;229:210-215.
11. Tarao K, Takemiya S, Tamai S, et al. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer. 1997;79:688-694.
12. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesaphagus for bleeding oesaphageal varices. Br J Surg. 1973;60:646-649.
13. Ercolani G, Grazi GL, Calliva R, et al. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery. 2000;127:464-471.
14. Couinaud C. Le foie. Etudes anatomiques et chirurgicales. Paris: Masson, 1957.
15. SPSS Base 8.0; Application Guide, SPSS Inc., Chicago, 1998.
16. Ko S, Nakajima Y, Kanehiro H, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg. 1996;224:591-595.
17. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
18. Nagao T, Inoue S, Yoshimi F, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg. 1990;211:28-33.
19. Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 1997;25:87-92.
20. Ping Poon RT, Fan ST, Lo C, et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma. Long-term results of treatment and prognostic factors. Ann Surg. 1999;229:216-222.
21. Shirabe K, Takenaka K, Taketomi A, et al. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer. 1996;77:1050-1055.
22. Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48:251-259.
23. Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995;108:768-775.
24. Ping Poon RT, Tat Fan S, Oi-Lin I, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Hepatology. 2000;189:500-507.
25. Chen PJ, Chen DS, Lai MY, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology. 1989;96:527-529.
26. Ikeda K, Saitoh S, Arase Y, et al. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1643 patients using statistical bias correlation with proportional hazard analysis. Hepatology. 1999;29:1124-1130.
27. Marks F, Bertsch S, Grimm W, et al. Hyperplastic transformation and tumor promotion in mouse epidermis: possible consequences of disturbances of endogenous mechanism controlling proliferation and differentiation. Carcinogenesis. 1987;2:97-116.
28. Taro K, Ohkawa S, Shimizu A, et al. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from antibody to hepatitis C virus-positive cirrhotic patients. Cancer. 1994;73:1149-1154.
29. Toyoda H, Kumada T, Nakano S, et al. The effect of retreatment with interferon-α on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C. Cancer. 2000;88:58-65.
30. Yoshida H, Shiratory Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med. 1999;131:174-181.
31. Yamanaka N, Tanaka T, Tanaka W, et al. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer. 1997;79:1509-1515.
32. Muto Y, Moriwaki H, Nimomiya M, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid in patients with hepatocellular carcinoma. N Engl J Med. 1996;334:1561-1567.